Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) — Stock Score Summary

Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) has a MoatMap StockRank of 70/100 based on Quality (83/100), Value (46/100), and Momentum (22/100) factor scores. The current signal is BUY. Changzhou Qianhong Biopharma is a regional Chinese biopharmaceutical firm that lacks the global scale, regulatory validation, and advanced biologics capabilities required to capture the CDMO pricing power cycle.

Changzhou Qianhong Biopharma Co., Ltd. is a leading Chinese biopharmaceutical company specializing in the research, development, and manufacture of biochemical drugs, particularly heparin sodium and pancreatin. The company maintains a highly integrated supply chain and holds international GMP certifications, allowing it to export active pharmaceutical ingredients (APIs) to global markets. Its strong R&D pipeline in cardiovascular and oncology therapeutics serves as a long-term growth driver.

Key Financial Metrics

Price$0.90
Market Cap$1.2B
P/E (TTM)23.23
P/E (Forward)20.13
Price/Book2.65
Return on Equity10.9%
Return on Invested Capital15.7%
Debt/Equity0.11
Gross Margin59.5%
Operating Margin29.8%
Revenue Growth-20.6%
Dividend Yield2.5%
Free Cash Flow$10M

Changzhou Qianhong Biopharma CO.,LTD operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Changzhou Qianhong Biopharma CO.,LTD’s (002550.SZ) StockRank?
MoatMap’s StockRank for Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) is 70/100, with a Buy signal. It is a composite of Quality (83), Value (46), and Momentum (22) factor ranks across MoatMap’s 19,000+ stock universe.
Does Changzhou Qianhong Biopharma CO.,LTD have an economic moat?
Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) has a Quality factor score of 83/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Changzhou Qianhong Biopharma CO.,LTD a buy, hold, or sell?
MoatMap’s current signal for Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) is Buy, based on a StockRank of 70/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Changzhou Qianhong Biopharma CO.,LTD in?
Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks002550.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock